Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - GROSS PROFIT
Gross Profit HALO - Halozyme Therapeutics, Inc.
637 M
LAST VALUE
32.66%
2 YEAR CAGR
35.06%
5 YEAR CAGR
29.36%
10 YEAR CAGR